Merikangas, KRI, Akiskal, HS, Angst, J, Greenberg, PE, Hirschfeld, RM, Petukhova, M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry
2007; 64: 543–52.
Kessler, RC, Chiu, WT, Demler, O, Merikangas, KR, Walters, EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry
2005; 62: 617–27.
Martin, DJ, Smith, DJ. Is there a clinical prodrome of bipolar disorder? A review of the evidence. Expert Rev Neurother
2013; 13: 89–98.
Ösby, U, Brandt, L, Correia, N, Ekbom, A, Sparén, P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry
2001; 58: 844–50.
Kemp, DE, Sylvia, LG, Calabrese, JR, Nierenberg, AA, Thase, ME, Reilly-Harrington, NA, et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand
2014; 129: 24–34.
McIntyre, R, Konarski, J, Soczynska, J, Wilkins, K, Panjwani, G, Bouffard, B, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv
2006; 57: 1140–4.
Moussavi, S, Chatterji, S, Verdes, E, Tandon, A, Patel, V, Ustun, B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet
2007; 370: 851–8.
Stommel, M, Given, BA, Given, CW. Depression and functional status as predictors of death among cancer patients. Cancer
2002; 94: 2719–27.
Glassman, AH, Shapiro, PA. Depression and the course of coronary artery disease. Am J Psychiatry
1998; 155: 4–11.
Ormel, J, Von Korff, M, Burger, H, Scott, K, Demyttenaere, K, Huang, YQ, et al. Mental disorders among persons with heart disease - results from World Mental Health surveys. Gen Hosp Psychiatry
2007; 29: 325–34.
Fiedorowicz, JG, He, J, Merikangas, KR. The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res
2011; 70: 145–54.
Herbst, S, Pietrzak, RH, Wagner, J, White, WB, Petry, NM. Lifetime major depression is associated with coronary heart disease in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med
2007; 69: 729–34.
Britvic, D, Maric, NP, Doknic, M, Pekic, S, Andric, S, Jasovic-Gasic, M, et al. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review. Psychiatr Danub
2013; 25: 410–5.
Collins, R. What makes UK Biobank special?
2012; 379: 1173–4.
Smith, DJ, Nicholl, B, Cullen, B, Martin, D, Ul-Haq, Z, Evans, J, et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172,751 participants. PLoS One
2013; 8: e75362.
Langan, J, Mercer, SW, Smith, DJ. Multimorbidity and mental health: can psychiatry rise to the challenge?
Br J Psychiatry
2013; 202: 391–3.
Ul-Haq, Z, Mackay, DF, Martin, D, Smith, DJ, Gill, JM, Nicholl, BI, et al. Heaviness, health and happiness: a cross-sectional study of 163 066 UK Biobank participants. J Epidemiol Community Health
2014; 68: 340–8.
Elderon, L, Whooley, MA. Depression and cardiovascular disease. Prog Cardiovasc Dis
2013; 55: 511–23.
Nordentoft, M, Wahlbeck, K, Hallgren, J, Westman, J, Osby, U, Alinaghizadeh, H, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One
2013; 8: e55176.
Kessler, RC, McGonagle, KA, Swartz, M, Blazer, DG, Nelson, CB. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. J Affect Disord
1993; 29: 85–96.
Hwu, H-G, Joyce, PR, Karam, EG, Lee, C-K, Lellouch, J, Wickramaratne, PJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA
1996; 276: 293–9.
De Hert, M, Correll, CU, Bobes, J, Cetkovich-Bakmas, M, Cohen, D, Asai, I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry
2011; 10: 52–77.
Lahti, M, Tiihonen, J, Wildgust, H, Beary, M, Hodgson, R, Kajantie, E, et al. Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychol Med
2012; 42: 2275–85.
Trivedi, MH, Lin, EH, Katon, WJ. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectr
2007; 12 (suppl 13): 1–27.
Lacro, JP, Dunn, LB, Dolder, CR, Leckband, SG, Jeste, DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry
2002; 63: 892–909.
Gadkari, AS, McHorney, CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really?
BMC Health Serv Res
2012; 12: 98.
Cramer, JA, Rosenheck, R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv
1998; 49: 196–201.
Hare, DL, Toukhsati, SR, Johansson, P, Jaarsma, T. Depression and cardiovascular disease: a clinical review. Eur Heart J
2014; 35: 1365–72.
Ramsey, CM, Leoutsakos, JM, Mayer, LS, Eaton, WW, Lee, HB. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study. J Affect Disord
2010; 125: 35–41.
Crump, C, Sundquist, K, Winkleby, MA, Sundquist, J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry
2013; 70: 931–9.
Weiner, M, Warren, L, Fiedorowicz, JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry
2011; 23: 40–7.
Shah, AS, Griffiths, M, Lee, KK, McAllister, DA, Hunter, AL, Ferry, AV, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ
2015; 350: g7873.
Towfighi, A, Saver, JL, Engelhardt, R, Ovbiagele, B. A midlife stroke surge among women in the United States. Neurology
2007; 69: 1898–904.
Carney, RM, Freedland, KE. Depression in patients with coronary heart disease. Am J Med
2008; 121 (suppl 2): S20–7.
Freedland, KE, Carney, RM, Skala, JA. Depression and smoking in coronary heart disease. Psychosom Med
2005; 67 (suppl 1): S42–6.
Whooley, MA, de Jonge, P, Vittinghoff, E, Otte, C, Moos, R, Carney, RM, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA
2008; 300: 2379–88.
Heffner, JL, Strawn, JR, DelBello, MP, Strakowski, SM, Anthenelli, RM. The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord
2011; 13: 439–53.
Ezzati, M, Henley, SJ, Thun, MJ, Lopez, AD. Role of smoking in global and regional cardiovascular mortality. Circulation
2005; 112: 489–97.
Rosmond, R, Björntorp, P. The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med
2000; 247: 188–97.
Watson, S, Gallagher, P, Ritchie, JC, Ferrier, IN, Young, AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry
2004; 184: 496–502.
Holsboer, F, Lauer, CJ, Schreiber, W, Krieg, JC. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology
1995; 62: 340–7.
Watson, S, Gallagher, P, Del-Estal, D, Hearn, A, Ferrier, IN, Young, AH. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med
2002; 32: 1021–8.
Khanzode, SD, Dakhale, GN, Khanzode, SS, Saoji, A, Palasodkar, R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep
2003; 8: 365–70.
Kendler, KS, Gardner, CO, Fiske, A, Gatz, M. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry
2009; 66: 857–63.
Scherrer, JF, Xian, H, Bucholz, KK, Eisen, SA, Lyons, MJ, Goldberg, J, et al. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med
2003; 65: 548–57.
McCaffery, JM, Frasure-Smith, N, Dube, MP, Theroux, P, Rouleau, GA, Duan, Q, et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med
2006; 68: 187–200.
Torkamani, A, Topol, EJ, Schork, NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics
2008; 92: 265–72.
Hansson, GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med
2005; 352: 1685–95.
Joynt, KE, Whellan, DJ, O'Connor, CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry
2003; 54: 248–61.
Rybakowski, JK, Wykretowicz, A, Heymann-Szlachcinska, A, Wysocki, H. Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry
2006; 60: 889–91.
Steinberg, HO, Chaker, H, Leaming, R, Johnson, A, Brechtel, G, Baron, AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest
1996; 97: 2601–10.
Strike, PC, Steptoe, A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis
2004; 46: 337–47.
Allison, DB, Newcomer, JW, Dunn, AL, Blumenthal, JA, Fabricatore, AN, Daumit, GL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med
2009; 36: 341–50.
Sernyak, MJ, Leslie, DL, Alarcon, RD, Losonczy, MF, Rosenheck, R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry
2002; 159: 561–6.
Baptista, T, Teneud, L, Contreras, Q, Alastre, T, Burguera, JL, de Burguera, M, et al. Lithium and body weight gain. Pharmacopsychiatry
1995; 28: 35–44.
McIntyre, RS, Mancini, DA, McCann, S, Srinivasan, J, Kennedy, SH. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord
2003; 5: 28–35.
Fava, M, Judge, R, Hoog, SL, Nilsson, ME, Koke, SC. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry
2000; 61: 863–7.
Faith, MS, Matz, PE, Jorge, MA. Obesity–depression associations in the population. J Psychosom Res
2002; 53: 935–42.